Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar ipsiety (< 20) Submitted: 6/27/2011 8:33:51 AM : Outperform Start Price: $35.02 LLY Score: +13.29

Low PE, look at ROE of 25.6%.

Report this Post Reply

Featured Broker Partners


Advertisement